# Dexamethasone as ESPB Adjuvant in Lumbar Laminectomy

> **NCT07429708** · PHASE3 · COMPLETED · sponsor: **Udayana University** · enrollment: 36 (actual)

## Conditions studied

- Laminectomy
- Postperative Pain Management
- Prostaglandin E2
- Lumbal Disc Herniation

## Interventions

- **DRUG:** Bilateral ESPB: Ropivacaine 0.375% + Dexamethasone 5mg
- **DRUG:** Bilateral ESPB: Ropivacaine 0.375%

## Key facts

- **NCT ID:** NCT07429708
- **Lead sponsor:** Udayana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-10
- **Primary completion:** 2025-08-25
- **Final completion:** 2025-09-01
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429708, "Dexamethasone as ESPB Adjuvant in Lumbar Laminectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07429708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*